Cargando…

Effects of Vaccination and Previous Infection on Omicron Infections in Children

Detalles Bibliográficos
Autores principales:	Lin, Dan-Yu, Gu, Yu, Xu, Yangjianchen, Zeng, Donglin, Wheeler, Bradford, Young, Hayley, Sunny, Shadia Khan, Moore, Zack
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511630/ https://www.ncbi.nlm.nih.gov/pubmed/36069811 http://dx.doi.org/10.1056/NEJMc2209371

Ejemplares similares

Effectiveness of Bivalent Boosters against Severe Omicron Infection
por: Lin, Dan-Yu, et al.
Publicado: (2023)

Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort study
por: Lin, Dan-Yu, et al.
Publicado: (2023)

Durability of Bivalent Boosters against Omicron Subvariants
por: Lin, Dan-Yu, et al.
Publicado: (2023)

Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina
por: Lin, Dan-Yu, et al.
Publicado: (2022)

Vaccination plus previous infection: protection during the omicron wave in Brazil
por: Cerqueira-Silva, Thiago, et al.
Publicado: (2022)

Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection
por: Blom, Kim, et al.
Publicado: (2022)

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
por: Altarawneh, Heba N., et al.
Publicado: (2022)

Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections
por: Altarawneh, Heba N., et al.
Publicado: (2022)

Omicron breakthrough infections in vaccinated or previously infected hamsters
por: Zhou, Jie, et al.
Publicado: (2023)

Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection
por: Carr, Edward J, et al.
Publicado: (2023)

Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants
por: Altarawneh, Heba N., et al.
Publicado: (2022)

Omicron subvariants escape antibodies elicited by vaccination and BA.2.2 infection
por: Yao, Lin, et al.
Publicado: (2022)

Evaluation of cross-neutralizing antibodies in children infected with omicron sub-variants
por: Peng, Weiyu, et al.
Publicado: (2023)

Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection
por: Jiang, Xiao-Lin, et al.
Publicado: (2023)

The Omicron COVID‐19 threat to dialysis patients is dramatically lower than previous variants
por: Al Madani, Ayman Kamal, et al.
Publicado: (2022)

Risk of omicron infection for high-risk older adults in long-term care facilities
por: Pallett, Scott J C, et al.
Publicado: (2023)

Decoupling of omicron variant infections and severe COVID-19
por: Madhi, Shabir A, et al.
Publicado: (2022)

Reduced sensitivity of antibody tests after omicron infection
por: Rössler, Annika, et al.
Publicado: (2023)

Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
por: Kuhlmann, Constanze, et al.
Publicado: (2022)

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection
por: Nemet, Ital, et al.
Publicado: (2021)

Omicron BA.1/1.1 SARS-CoV-2 Infection among Vaccinated Canadian Adults
por: Brown, Patrick E., et al.
Publicado: (2022)

Protection against Omicron from Vaccination and Previous Infection in a Prison System
por: Chin, Elizabeth T., et al.
Publicado: (2022)

Characteristics and implications of Omicron variant associated digestive system infections – Correspondence
por: Shi, Yunjie, et al.
Publicado: (2022)

Clinical features of SARS-CoV-2 Omicron BA.2; Lessons from previous observations – Correspondence
por: Sahebi, Saeed, et al.
Publicado: (2022)

Clinical severity of omicron lineage BA.2 infection compared with BA.1 infection in South Africa
por: Wolter, Nicole, et al.
Publicado: (2022)

Co-infection with SARS-CoV-2 omicron BA.1 and BA.2 subvariants in a non-vaccinated woman
por: Vatteroni, Maria Linda, et al.
Publicado: (2022)

Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera
por: Wang, Xun, et al.
Publicado: (2022)

Finite neutralisation breadth of omicron after repeated vaccination
por: Zhu, Yufang, et al.
Publicado: (2022)

Efficacy of vaccination and previous infection against the Omicron BA.1 variant in Syrian hamsters
por: Halfmann, Peter J., et al.
Publicado: (2022)

The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era
por: Boaventura, Viviane S, et al.
Publicado: (2023)

Protection Associated with Previous SARS-CoV-2 Infection in Nicaragua
por: Maier, Hannah E., et al.
Publicado: (2022)

Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection
por: Rössler, Annika, et al.
Publicado: (2022)

Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases
por: Otiniano, Armelle, et al.
Publicado: (2022)

Three-dose vaccination elicits neutralising antibodies against omicron
por: Wu, Mary, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Symptomatic Infections in Previously Infected or Vaccinated South African Healthcare Workers
por: Nunes, Marta C., et al.
Publicado: (2022)

Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology
por: de Gier, Brechje, et al.
Publicado: (2023)

Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine
por: Prendecki, Maria, et al.
Publicado: (2021)

Low neutralisation of the omicron BA.2 sublineage in boosted individuals who had breakthrough infections
por: Karaba, Andrew H, et al.
Publicado: (2022)

Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection
por: Boucau, Julie, et al.
Publicado: (2022)

Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease
por: Ikeda, Daisuke, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8g2qvi2aa23mj8dlcucld7spc2